Summary
The metabolic response to glucose infusion in anaesthetized normal and pancreatectomized dogs has been assessed. Normoglycaemia was achieved in the diabetic dogs with an external artificial B-cell which administered insulin into the peripheral circulation. No differences were found in the levels of blood glucose, glucagon, lactate, pyruvate and plasma non-esterified fatty acids, either in the fasting state or in response to glucose infusion. However, compared to normal animals normoglycaemic diabetic dogs had significantly elevated circulating levels of insulin and alanine at all times. Fasting levels of the same hormones and metabolites were also measured in conscious dogs. Blood pyruvate levels were higher, and plasma non-esterified fatty acid levels lower, in the anaesthetized animals. There were also minor but consistent changes in blood glucose and plasma insulin while glucagon, lactate and alanine levels were unaffected by anaesthesia. In conclusion, controlled barbiturate anaesthesia has relatively minor effects on the metabolic and hormonal status of the dog. The metabolic and hormonal response to glucose infusion in pancreatectomized dogs treated with an artificial B-cell was almost entirely normalized, except for peripheral hyperinsulinaemia and hyperalaninaemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W, Schipper H, Gander R (1974) Clinical control of diabetes by the artificial pancreas. Diabetes 23: 397–404
Marliss EB, Murray FT, Stokes EF, Zinman B, Nakhooda AF, Denoga A, Leibel BS, Zingg W, Albisser AM (1977) Normalisation of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes 26: 663–672
Zinman B, Stokes EF, Albisser AM, Hanna AK, Minuk HL, Stein AN, Leibel BS, Marliss EB (1979) The metabolic response to glycemic control by the artificial pancreas in diabetic man. Metabolism 28: 511–518
Noy G (1979) Metabolic effects of glucose clamping at normal and hyperglycemic levels. Symposium on “Carbohydrate Metabolism: Quantitative Physiology and Mathematical Modeling”, Padova
Zinman B, Murray FT, Vranic M, Albisser AM, Leibel BS, McClean PA, Marliss EB (1977) Glucoregulation during moderate exercise in insulin treated diabetics. J Clin Endocrinol Metab 45: 641–652
Murray FT, Zinman B, McClean PA, Denoga A, Albisser AM, Leibel BS, Nakhooda AF, Zamel N, Marliss EB (1977) The metabolic response to moderate exercise in diabetic man receiving intravenous and subcutaneous insulin. J Clin Endocrinol Metab 44: 708–720
Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W (1974) An artificial endocrine pancreas. Diabetes 23: 389–396
Albisser AM, Ellman J, Hanna A, Goriya Y, Minuk H (1978) Continuous blood glucose analysis in vitro and in vivo. Diabetologia 15: 303–308
Herbert V, Law KD, Gottlieb CW, Bleicher SJ (1974) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 39: 1090
Girard JR, Cuendet GS, Marliss EB, Kervran A, Rieurort M, Assan R (1973) Fuels, hormones and liver metabolism at term and during the early postnatal period in the rat. J Clin Invest 52: 3190–3200
Ho RJ (1970) Radiochemical assay of long-chain fatty acids using 63Ni as a tracer. Anal Biochem 36: 105–113
Botz CK, Marliss EB, Albisser AM (1979) Blood glucose regulation using closed- and open-loop insulin delivery systems. II. Peripheral primed square waves. Diabetologia 17: 45–49
Botz CK, Albisser AM, Leibel BS, Zingg W, Gander RE (1976) Comparison of peripheral and portal routes of insulin infusion by a computer controlled insulin infusion system (artificial endocrine pancreas). Diabetes 25: 691–700
Goriya Y, Bahoric A, Marliss EB, Zinman B, Albisser AM (1979) Glycemic regulation using a programmed insulin delivery device. III. Long term studies. Diabetes 28: 558–564
Hanna AK, Zinman B, Nakhooda AF, Minuk HL, Stokes EF, Albisser AM, Leibel BS, Marliss EB (in press) Insulin, glucagon and amino acids during glycemic control by the artificial pancreas in diabetic man. Metabolism
Albisser AM, Botz CK, Leibel BS (1979) Blood glucose regulation using an open-loop insulin delivery system in pancreatectomized dogs given glucose infusions. I. Portal square waves. Diabetologia 16: 129–133
Cherrington AD, Vranic M (1974) Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs. Metabolism 23: 729–744
Cherrington AD, Lacy WW, Chiasson JL (1978) Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 59: 664–677
Chiasson JL, Liljenquist JE, Finger FE, Lacy WW (1976) Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs. Diabetes 25: 283–291
Felig P, Wahren J, Sherwin R, Palaiologos G (1977) Amino acid and protein metabolism in diabetes mellitus. Arch Intern Med 137: 507–513
Cherrington AD, Kawamori R, Pek S, Vranic M (1974) Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels. Diabetes 23: 805–815
Sasaki H, Rubalcava B, Baetens D, Blazquez C, Srikant B, Orci L, Unger RH (1975) Identification of glucagon in the gastro-intestinal tract. J Clin Invest 56: 135–145
Lefebvre PJ, Luyckx AS (1978) Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology 103: 1579–1582
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albisser, A.M., Zinman, B., Marliss, E.B. et al. The metabolic and hormonal responses to glucose infusion in anaesthetized normal and diabetic dogs controlled by an artificial B-cell. Diabetologia 18, 479–485 (1980). https://doi.org/10.1007/BF00261704
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00261704